ANTISENSE THERAPEUTICS LIMITED (ANP)

The development of novel antisense pharmaceuticals for commercially important human conditions.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
ANP	0.009	0%	0.009	0.010	0.000	0.000	0.000	0

ANTISENSE THERAPEUTICS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	ANP
Securities	ASX Code, Security Description ------------------------------ ANP, Ordinary Fully Paid
Official Listing Date	20 December, 2001
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.antisense.com.au/
Registered Office Address	Level 1, 10 Wallace Avenue, TOORAK, VIC, AUSTRALIA, 3142
Head Office Telephone	(03) 9827 8999
Head Office Fax	(03) 9827 1166
Share Registry	BOARDROOM PTY LIMITED LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	(02) 9290 9600

Directors / Senior Management
Mr Robert Moses (Chairman) Mr Mark Diamond (Managing Director, CEO) Mr Chris Belyea (Non Exec. Director) Prof. Graham Mitchell (Non Exec. Director) Mr Phillip Hains (CFO) Mr Simon Watkin (Investor Relations)

Company Secretary	Mr Phillip Hains
Principal Activities	The development of novel antisense pharmaceuticals for commercially important human conditions.

ANTISENSE THERAPEUTICS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
13/05/2013		Change of Director's Interest Notice - RM	2	PDF
01/05/2013		ATL1102 for Multiple Sclerosis -Toxicology Study to Commence	2	PDF
30/04/2013		Appendix 4C - quarterly	5	PDF
17/04/2013		Change of Director's Interest Notice (MD)	2	PDF
10/04/2013		ATL1103 Phase II trial - dosing of patients commences	2	PDF
08/04/2013		Antisense Newsletter	5	PDF
25/03/2013		Change of Director's Interest Notice - MD	2	PDF
22/03/2013		ATL1103 Phase I data presentation at Acromegaly Conference	1	PDF
19/03/2013		ATL1102 Development and Agreement Update	2	PDF
15/03/2013		ANP to Present at ROTH Capital Partners Conference	1	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
22 May 2013	0.009	0%	0.009	0.009	480,000
21 May 2013	0.009	-10%	0.010	0.009	4,190,000
20 May 2013	0.010	0%	0.010	0.010	741,898
17 May 2013	0.010	0%	0.011	0.010	2,573,509
16 May 2013	0.010	11.11%	0.010	0.010	1,554,297

* Volume of shares shown represents only those shares traded on ASX.

ANTISENSE THERAPEUTICS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ANP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ANP

Warrants & Structured Products

No warrants & Structured Products are available over the security ANP

ASX CFDs

No Contracts For Differences are available over the security ANP

MyASX: Login | Sign up